HOME >> BIOLOGY >> NEWS
Modeling lung cancer

In a new report in the February 15th issue of G&D, Dr. Martin McMahon (UCSF) and colleagues present a novel mouse model of non-small cell lung cancer, which will serve as a useful tool to test the efficacy of novel chemotherapeutic drug therapies in the early stages of lung tumorigenesis. Their paper provides evidence to support the use of a relatively new class of drugs, called MEK inhibitors, for lung cancer patients whose tumors contain mutations in the BRaf gene.

BRaf is one of three members of the RAF kinase family, which, upon activation, induces the mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) cell signaling pathway and promotes cell proliferation. Activating mutations in BRaf (ie., a mutation that causes the activation of the catalytic activity of the BRaf protein) are implicated in a number of different human cancers, including the majority of melanoma cancers, as well as in colorectal, thyroid, ovarian and non-small cell lung cancers.

Dr. McMahon and colleagues engineered a strain of mice to carry a version of the BRaf gene that the researchers could activate at will both temporally and spatially. After activating BRaf specifically in the lungs of mice at 6-8 weeks of age, the researchers observed that the BRaf-mutant mice (or BRaf(VE), as they are known) developed multiple lung tumors that were pathologically similar to human lung tumors thereby establishing BRaf as a bona fide oncoprotein.

Administration of the MEK-inhibitor, PD0325901 (developed by Pfizer, and now in clinical trials) effectively halted tumor progression in BRaf(VE) mice. Interestingly, however, without pharmacological intervention, the BRaf-mutant tumors eventually stopped proliferating, and entered into a senescent state. This senescent state could be overcome by concomitant mutation of either p53 or p16(Ink4a)/p19(Arf), enabling tumors to become adenocarcinomas.

Dr. McMahon said that the striking response
'"/>

Contact: Heather Cosel
coselpie@cshl.edu
Cold Spring Harbor Laboratory
12-Feb-2007


Page: 1 2

Related biology news :

1. Modeling the restless brain
2. Modeling alien invasions: Plasticity may hold the key to prevention
3. Symposium Environmental Change in Siberia -- Insights From Earth Observation and Modeling
4. Burnham Institute for Medical Research & UC San Diego establish Joint Center for Molecular Modeling
5. Students from U of Colorado at Boulder and Harvard triumph in SIAMs Math Contest in Modeling
6. Modeling head and neck cancers
7. Protein chatter linked to cancer activation
8. Newly created cancer stem cells could aid breast cancer research
9. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
10. ESF EURYI award winner aims to stop cancer cells reading their own DNA
11. No evidence that widely prescribed statins protect against prostate cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/17/2018)... ... August 16, 2018 , ... With increasing safety requirements, ... basic research projects, are presenting multiple challenges. To be successful in such a competitive ... the different aspects of the multiple tasks needed to develop a new drug or ...
(Date:8/15/2018)... YONKERS, N.Y. (PRWEB) , ... August 15, 2018 , ... ... bearings for the pump and marine industries, has updated its ISO quality management certification ... quality management principles including a strong customer focus and the company’s ability to offer ...
(Date:8/14/2018)... Calif. (PRWEB) , ... August 13, 2018 , ... ... valuable because it provides information on endogenous compounds produced in the body as ... recognized, be it from nutritional habits or physical activity. , By performing ...
Breaking Biology News(10 mins):
(Date:9/12/2018)... , ... September 12, 2018 , ... ... a quality management professional and former Senior Director of Regulatory Affairs and Quality ... , As Senior Director of Regulatory Affairs and Quality Systems at WellDoc, Inc., ...
(Date:9/7/2018)... ... 2018 , ... Akadeum Life Sciences today announced it has appointed George Dunbar ... leader of numerous biotech companies. , He most recently served as president and ... Street Capital in St. Louis, MO. Prior to ISTO, he was a Venture ...
(Date:8/29/2018)... ... ... Cognition Corporation ®, a software company specializing in medical device compliance ... , Ryan Ward, Director of Engineering at Zimmer Biomet, has been announced as a ... with Zimmer Biomet for almost 15 years, Mr. Ward will focus his talk about ...
(Date:8/26/2018)... Calif. (PRWEB) , ... August 23, 2018 , ... ... events for tech innovators, engineers, and scientists from around the world, will host ... 2018 will cover an array of industries and disciplines, encompassing various research areas ...
Breaking Biology Technology:
Cached News: